drug

donanemab-azbt

1 story · latest Oct 28, 2026

Follow donanemab-azbt. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Jul 2024 · BLA761248
Brand: Kisunla

Relationships

Developed by Eli Lilly

Timeline

Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipeline

Oct 28Quarterly updateBristol Myers Squibb Eli LillyUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.